HNF1A and type 2 diabetes mellitus: Though the clinical manifestations of HNF1-alpha MODY overlap with type 1 diabetes mellitus (T1DM) and T2DM, patients with HNF1-alpha MODY are generally more sensitive to sulfonylureas (9, 10).